Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bright Giant is a Germany-based life science software company focused on AI-powered analysis of small-molecule LC-MS/MS data. Founded in 2019 as a spin-out from Friedrich Schiller University Jena, the company commercializes SIRIUS and related web services for non-academic users, helping researchers identify unknown metabolites and other small molecules from mass spectrometry data. Its software supports workflows such as feature detection, molecular formula annotation, structure annotation, compound class prediction, substructure annotation, and spectral library matching. Bright Giant serves customers across pharmaceutical, biotech, food, and analytical testing markets and also offers custom hosting, tailored workflows, database generation, and machine-learning model training. The company appears to be a tools/platform provider rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bright Giant.